Rani Therapeutics Holdings, Inc.
NASDAQ:RANI · NASDAQ Global Market
-$0.04 today
Vol 0.30M · Avg 1.15M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+59.67%
Period High
$2.85
Period Low
$0.41
Latest
$0.78
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Cybin Inc.
CYBN
$413.02M
Tonix Pharmaceuticals Holding Corp.
NASDAQ:TNXP
$191.45M
Innate Pharma S.A.
NASDAQ:IPHA
$169.96M
Molecular Partners AG
NASDAQ:MOLN
$143.29M
Milestone Pharmaceuticals Inc.
NASDAQ:MIST
$111.66M
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBP
$103.54M
Cardiff Oncology, Inc.
NASDAQ:CRDF
$82.73M
Elicio Therapeutics, Inc.
NASDAQ:ELTX
$73.48M
Sangamo Therapeutics, Inc.
NASDAQ:SGMO
$70.43M
Applied Therapeutics, Inc.
APLT
$14.86M
What is the latest RANI filing?
The latest filing shown is 4 dated Jun 5, 2026.
How many recent filings does RANI have?
Intrinsic Alpha currently shows 20 recent filings for RANI.
Explore More
Continue the stock analysis
Jump to another research area for this company.